To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDC5LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
484 supporting clones for gene CDC5L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM829346 Ascites, stomach .a 1 to 585 1 to 585   tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
DC422730 uterus .a 2 to 545 1 to 544       544/544
(100 %)
0 diff
(100 %id)
DW448485 Liver .a 14 to 206 17 to 207       191/207
(92 %)
6 diff
(97.2 %id)
DC374775 brain .a 15 to 587 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
AU279445   .a 20 to 581 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DC337418 substantia nigra .a 34 to 621 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
BF574519 muscle (skeletal) .a 35 to 719 1 to 681       681/685
(99 %)
25 diff
(96.4 %id)
DC363350   .a 43 to 581 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
DC299556   .a 45 to 612 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC371211   .a 45 to 604 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BG497404 lung, mucoepidermoid carcinoma .a 51 to 741 1 to 694       694/910
(76 %)
7 diff
(99.3 %id)
BG528093 lung, mucoepidermoid carcinoma .a 51 to 742 1 to 689       689/879
(78 %)
22 diff
(97.5 %id)
BP231294 muscle .a 52 to 622 1 to 572       572/583
(98 %)
5 diff
(99.2 %id)
BG495174 lung, mucoepidermoid carcinoma .a 52 to 749 1 to 698       698/708
(98 %)
24 diff
(96.7 %id)
NM_001253.2   .a 52 to 3050 1 to 2999 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 2999/2999
(100 %)
2 diff
(100.0 %id)
DA970040 stomach .a 53 to 616 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB081991 testis .a 54 to 586 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
BM804765 ovary (pool of 3) .a 67 to 849 1 to 789   tiling clone,   789/1032
(76 %)
11 diff
(99.0 %id)
CB144032 Liver .a 71 to 503 1 to 433       433/433
(100 %)
0 diff
(100 %id)
BG121920 adenocarcinoma, cell line, Liver .a 116 to 840 1 to 720       720/885
(81 %)
17 diff
(98.1 %id)
CK024078 brain/CNS, Human Brain - Frontal Cortex .a 177 to 841 1 to 664   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 664/694
(95 %)
15 diff
(97.9 %id)
DA293782 hippocampus .a 179 to 753 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB134482 thymus .a 182 to 735 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
AV762357 bone marrow .a 186 to 829 1 to 641       641/664
(96 %)
11 diff
(98.4 %id)
BP373950 umbilical cord .a 187 to 765 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BP373957 umbilical cord .a 187 to 770 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP373963 umbilical cord .a 187 to 768 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BP373966 umbilical cord .a 187 to 768 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP373978 umbilical cord .a 187 to 769 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP373981 umbilical cord .a 187 to 767 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP374036 umbilical cord .a 187 to 769 1 to 582       582/582
(100 %)
10 diff
(98.3 %id)
BP374037 umbilical cord .a 187 to 768 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
CD103634 Pooled-Skin .a 188 to 920 1 to 734       734/735
(99 %)
8 diff
(99.0 %id)
AL710914 human skeletal muscle .a 189 to 895 1 to 709       709/710
(99 %)
7 diff
(99.1 %id)
DA619433   .a 189 to 785 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
DA306735 hippocampus .a 190 to 759 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA528778 brain .a 191 to 788 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
BP315773 mammary gland .a 191 to 774 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA182689 amygdala .a 192 to 771 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA928103 small intestine .a 192 to 767 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
AK128737 hippocampus .a 193 to 3028 1 to 2836 S800L available from FLJ,   2836/2836
(100 %)
1 diff
(100.0 %id)
FN062435 breast carcinoma .a 193 to 294 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
CD101983 Blood vessels - aorta, basilar and artery .a 193 to 849 1 to 662       662/772
(85 %)
9 diff
(98.9 %id)
DA311260 hippocampus .a 194 to 763 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA473100   .a 194 to 748 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA489843 brain .a 194 to 583 2 to 391   capped   390/390
(100 %)
0 diff
(100 %id)
DA490832 brain .a 194 to 785 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA498802 brain .a 194 to 754 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AU076696   .a 194 to 356 1 to 163       163/167
(97 %)
4 diff
(97.7 %id)
BP238575 Liver .a 194 to 808 1 to 615       615/615
(100 %)
5 diff
(99.2 %id)
BP280649   .a 194 to 776 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA741545   .a 194 to 714 2 to 524   capped   521/523
(99 %)
3 diff
(99.5 %id)
DA886229   .a 194 to 763 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA904847   .a 194 to 732 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
DA975582 synovial membrane tissue from rheumatioidarthritis .a 194 to 754 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DB110992 thymus .a 194 to 765 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BP199184 brain .a 195 to 780 1 to 586       586/586
(100 %)
3 diff
(99.5 %id)
DA618507   .a 195 to 762 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA788119 brain .a 195 to 688 2 to 495   capped   494/494
(100 %)
2 diff
(99.6 %id)
DA822733 pericardium .a 195 to 762 2 to 570   capped   567/569
(99 %)
4 diff
(99.3 %id)
BM194271 leukopheresis .a 195 to 506 1 to 312       312/313
(99 %)
32 diff
(89.8 %id)
BP377923 uterus .a 195 to 744 1 to 551       551/551
(100 %)
19 diff
(96.6 %id)
DA019320   .a 196 to 753 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
DA368079 subthalamic nucleus .a 196 to 778 2 to 585   capped   584/584
(100 %)
5 diff
(99.2 %id)
BP220374 colon .a 196 to 746 1 to 551       551/559
(98 %)
12 diff
(97.9 %id)
DA437700 tongue, tumor tissue .a 196 to 749 2 to 555   capped   554/555
(99 %)
2 diff
(99.7 %id)
DA451968 tongue, tumor tissue .a 196 to 765 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AL706102 human skeletal muscle .a 196 to 949 1 to 754       754/755
(99 %)
2 diff
(99.8 %id)
DA490730 brain .a 196 to 703 2 to 510   capped   509/509
(100 %)
2 diff
(99.7 %id)
BP243429 Liver .a 196 to 773 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BF679988 Prostate .a 196 to 847 1 to 656       656/890
(73 %)
20 diff
(97.8 %id)
BP315496 mammary gland .a 196 to 779 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
DA948628 Spleen .a 196 to 746 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DB235595 trachea .a 196 to 780 2 to 582   capped   581/581
(100 %)
8 diff
(98.7 %id)
BP194613 brain .a 197 to 778 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA038735   .a 197 to 779 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA107203 cerebellum .a 197 to 741 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA170615 amygdala .a 197 to 768 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA285849 corpus callosum .a 197 to 659 2 to 465   capped   464/493
(94 %)
2 diff
(99.6 %id)
DA381946 thalamus .a 197 to 759 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA397243 thalamus .a 197 to 777 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA419814 cord Blood .a 197 to 749 2 to 555   capped   554/564
(98 %)
1 diff
(99.9 %id)
CD610982   .a 197 to 829 31 to 663       633/674
(93 %)
9 diff
(98.7 %id)
CD610983   .a 197 to 829 636 to 10       627/666
(94 %)
7 diff
(99.0 %id)
DA441505 tongue, tumor tissue .a 197 to 774 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DW418207 Liver .a 197 to 479 18 to 304       287/304
(94 %)
9 diff
(97.1 %id)
DW457913 Liver .a 197 to 338 18 to 159       142/159
(89 %)
6 diff
(96.3 %id)
DW462547 Liver .a 197 to 546 17 to 368       352/368
(95 %)
10 diff
(97.3 %id)
DW463410 Liver .a 197 to 295 18 to 116       99/116
(85 %)
6 diff
(94.9 %id)
DA505205 brain .a 197 to 748 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA507897 brain .a 197 to 780 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA556810   .a 197 to 737 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BG722285 testis .a 197 to 807 1 to 611       611/612
(99 %)
5 diff
(99.2 %id)
BP284089 bone marrow .a 197 to 788 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
DA660478   .a 197 to 770 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA693475   .a 197 to 781 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DA738784   .a 197 to 746 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA762657 tongue .a 197 to 759 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA773359 brain .a 197 to 749 2 to 554   capped   553/561
(98 %)
0 diff
(100 %id)
DA774305 brain .a 197 to 766 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA780498 brain .a 197 to 759 2 to 565   capped   562/564
(99 %)
4 diff
(99.3 %id)
DA789799 brain .a 197 to 775 2 to 582   capped   579/581
(99 %)
3 diff
(99.5 %id)
DA794751 brain .a 197 to 749 2 to 556   capped   553/564
(98 %)
5 diff
(99.2 %id)
BP315437 mammary gland .a 197 to 779 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM834441 stomach .a 197 to 771 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BP341018 stomach mucosa .a 197 to 778 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP341429 stomach mucosa .a 197 to 781 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP350464 brain .a 197 to 779 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP358024 mammary gland .a 197 to 780 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP361851 thalamus .a 197 to 778 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB124630 thymus .a 197 to 761 2 to 568   capped   565/567
(99 %)
3 diff
(99.5 %id)
DA020536   .a 198 to 766 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA276877 corpus callosum .a 198 to 763 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA395128 thalamus .a 198 to 788 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA441827 tongue, tumor tissue .a 198 to 749 2 to 553   capped   552/559
(98 %)
2 diff
(99.7 %id)
DA816978   .a 198 to 767 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AU135978 placenta .a 198 to 930 2 to 736   capped   735/735
(100 %)
6 diff
(99.2 %id)
DA888908   .a 198 to 754 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA939260 Spleen .a 198 to 784 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB031826 testis .a 198 to 781 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
AL710062 human skeletal muscle .a 199 to 724 1 to 526       526/526
(100 %)
17 diff
(96.8 %id)
BP245238 Kidney .a 199 to 763 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
BG540599 lung .a 199 to 843 1 to 648       648/799
(81 %)
25 diff
(96.9 %id)
DA713957   .a 199 to 766 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
CV574068 cornea, eye .a 199 to 730 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
DW420879 Liver .a 200 to 482 17 to 299       283/299
(94 %)
8 diff
(97.4 %id)
BG614948 embryonal carcinoma, testis .a 200 to 809 1 to 627       627/842
(74 %)
19 diff
(97.8 %id)
BP312619 mammary gland .a 200 to 783 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP353739   .a 200 to 778 1 to 581       581/581
(100 %)
16 diff
(97.3 %id)
BP353743   .a 200 to 781 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA619420   .a 201 to 795 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
BJ992593 hepatoblastoma .a 202 to 686 1 to 485       485/485
(100 %)
0 diff
(100 %id)
DA961970 Spleen .a 202 to 756 2 to 558   capped   557/557
(100 %)
6 diff
(99.0 %id)
BP359132 mammary gland .a 202 to 783 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA422475 cervix .a 203 to 755 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA452961 tongue, tumor tissue .a 203 to 769 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA780449 brain .a 203 to 783 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BP313986 mammary gland .a 203 to 787 1 to 584       584/584
(100 %)
12 diff
(98.0 %id)
DB255839 uterus .a 203 to 763 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB258672 uterus .a 203 to 762 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB259734 uterus .a 203 to 768 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
CN314394 embryonic stem cells, cell lines H1, H7, andH9 .a 204 to 881 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
DB272440 uterus .a 204 to 753 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA501759 brain .a 205 to 763 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BY797699 eye .a 206 to 798 1 to 593       593/595
(99 %)
1 diff
(99.9 %id)
BX331396 Neuroblastoma Cot 10-normalized .a 207 to 1204 1 to 991       991/994
(99 %)
22 diff
(97.8 %id)
BI823054 pooled brain, lung, testis .a 207 to 975 1 to 773       773/773
(100 %)
16 diff
(98.0 %id)
BM450338 eye, retinoblastoma .a 207 to 1066 20 to 884       865/1021
(84 %)
16 diff
(98.5 %id)
TI_57201623   .a 207 to 975 28 to 800       773/800
(96 %)
21 diff
(97.4 %id)
CR594844 T cells (Jurkat cell line) Cot10-normalized .a 208 to 2401 1 to 2194       2194/2194
(100 %)
0 diff
(100 %id)
AL558731 T cells from T cell leukemia .a 208 to 1066 1 to 859       859/859
(100 %)
7 diff
(99.2 %id)
BG327622 Kidney, renal cell adenocarcinoma .a 208 to 841 1 to 635       635/679
(93 %)
13 diff
(98.1 %id)
BG424071 Kidney, renal cell adenocarcinoma .a 208 to 849 1 to 641       641/911
(70 %)
15 diff
(98.4 %id)
BM925609 brain .a 208 to 1066 11 to 875       865/1071
(80 %)
23 diff
(97.9 %id)
CN314387 embryonic stem cells, DMSO-treated H9 cellline .a 209 to 984 1 to 776       776/776
(100 %)
1 diff
(99.9 %id)
DA494702 brain .a 209 to 779 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
T60967 Liver .a 209 to 291 4 to 86       83/86
(96 %)
3 diff
(96.6 %id)
BU508497 leiomyosarcoma, uterus .a 209 to 1013 11 to 822       812/1008
(80 %)
22 diff
(97.9 %id)
CN314386 embryonic stem cells, cell lines H1, H7, andH9 .a 210 to 875 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
AA219720 brain, neuroepithelial cells .a 210 to 651 1 to 443       443/443
(100 %)
4 diff
(99.1 %id)
AL135197 melanoma (MeWo cell line) .a 211 to 897 1 to 687       687/687
(100 %)
2 diff
(99.8 %id)
BQ423785 melanotic melanoma, skin .a 211 to 983 34 to 813       780/853
(91 %)
16 diff
(98.2 %id)
BC001568 Placenta, choriocarcinoma .a 212 to 3028 1 to 2817 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 2817/2817
(100 %)
0 diff
(100 %id)
DN993895 brain, whole brain .a 212 to 871 8 to 667       660/667
(98 %)
7 diff
(99.0 %id)
AA305877   .a 213 to 676 1 to 464       464/464
(100 %)
1 diff
(99.8 %id)
DA304002 hippocampus .a 213 to 749 2 to 538   capped   537/546
(98 %)
1 diff
(99.9 %id)
CN314384 embryonic stem cells, DMSO-treated H9 cellline .a 213 to 877 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
BF795413 lymph, lymphoma, cell line .a 213 to 749 1 to 531       529/777
(68 %)
22 diff
(97.2 %id)
DB088917 testis .a 213 to 761 2 to 551   capped   548/550
(99 %)
1 diff
(99.9 %id)
BX446071 T cells (Jurkat cell line) .a 215 to 1045 1 to 824       824/828
(99 %)
21 diff
(97.5 %id)
BG502998 embryonal carcinoma, testis .a 215 to 879 1 to 666       666/666
(100 %)
6 diff
(99.1 %id)
N56376   .a 217 to 401 1 to 182       182/184
(98 %)
5 diff
(97.3 %id)
BU071659 insulinoma, Pancreas .a 219 to 829 1 to 611     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 611/611
(100 %)
3 diff
(99.6 %id)
BG390164 embryonal carcinoma, cell line, testis .a 220 to 909 1 to 688       688/736
(93 %)
7 diff
(99.1 %id)
AA318063 retina .a 226 to 540 1 to 315       315/315
(100 %)
2 diff
(99.4 %id)
AW954903   .a 227 to 846 1 to 622       622/638
(97 %)
11 diff
(98.3 %id)
AA130725   .a 227 to 639 1 to 415       414/415
(99 %)
7 diff
(98.4 %id)
BM127700 Islets of Langerhans, Pancreas .a 228 to 810 1 to 583       583/587
(99 %)
6 diff
(99.0 %id)
AB007892 brain .a 229 to 6432 1 to 6201 exact tiling clone, available from KIAA,   6201/6201
(100 %)
6 diff
(100.0 %id)
BE541230 cervix .a 233 to 931 1 to 711       711/730
(97 %)
29 diff
(96.1 %id)
AW383312 head_neck .a 236 to 590 377 to 24       354/382
(92 %)
12 diff
(96.9 %id)
BM894481 insulinoma, Pancreas .a 238 to 780 1 to 543   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 543/543
(100 %)
5 diff
(99.1 %id)
BU195085 melanotic melanoma, skin .a 243 to 1057 1 to 819       819/920
(89 %)
5 diff
(99.5 %id)
BE884277 leiomyosarcoma, uterus .a 244 to 912 1 to 667       667/670
(99 %)
22 diff
(96.8 %id)
CX164734 human embryonic stem cells differentiated toan early endodermal cell type .a 250 to 1075 1 to 826       826/826
(100 %)
0 diff
(100 %id)
CN314385 embryonic stem cells, cell lines H1, H7, andH9 .a 262 to 1017 13 to 768       756/768
(98 %)
7 diff
(99.1 %id)
CN314393 embryonic stem cells, cell lines H1, H7, andH9 .a 293 to 736 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
DA386286 thalamus .a 309 to 899 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
CV023034 mixed .a 311 to 882 1 to 572       572/576
(99 %)
2 diff
(99.7 %id)
TI_1948148248   .a 311 to 909 120 to 721       602/1357
(44 %)
14 diff
(99.0 %id)
TI_1948148283   .a 311 to 805 128 to 624       497/1259
(39 %)
23 diff
(98.2 %id)
TI_1948148284   .a 311 to 1042 130 to 867       738/1392
(53 %)
21 diff
(98.5 %id)
TI_1948148546   .a 311 to 849 123 to 663       541/1267
(42 %)
17 diff
(98.7 %id)
TI_1948148547   .a 311 to 1013 136 to 836       701/1419
(49 %)
19 diff
(98.7 %id)
TI_1948148584   .a 311 to 847 124 to 663       540/1215
(44 %)
19 diff
(98.5 %id)
TI_1948148585   .a 311 to 1223 134 to 1053   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 920/1358
(67 %)
26 diff
(98.1 %id)
TI_1948148840   .a 311 to 844 124 to 657       534/1285
(41 %)
14 diff
(99.0 %id)
TI_1948148841   .a 311 to 1213 128 to 1030       903/1362
(66 %)
26 diff
(98.1 %id)
TI_1948148879   .a 311 to 1211 126 to 1019       894/1302
(68 %)
15 diff
(98.9 %id)
TI_1948149159   .a 311 to 826 123 to 637       515/1246
(41 %)
22 diff
(98.3 %id)
TI_1948149160   .a 311 to 1209 131 to 1039       909/1387
(65 %)
35 diff
(97.5 %id)
TI_1948149205   .a 311 to 747 124 to 560       437/1280
(34 %)
6 diff
(99.6 %id)
TI_1948149206   .a 311 to 1335 128 to 1153       1025/1367
(74 %)
54 diff
(96.1 %id)
TI_1948155305.
matches multiple genes
  .a 311 to 1209 128 to 1020     also hits gene QSOX1 893/1356
(65 %)
21 diff
(98.5 %id)
U86753   .a 311 to 2719 1 to 2409 exact     2409/2409
(100 %)
0 diff
(100 %id)
BE617311 adenocarcinoma, colon .a 319 to 999 1 to 674       674/674
(100 %)
16 diff
(97.7 %id)
BP246589 Kidney .a 323 to 909 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
D85423   .a 332 to 795 1 to 464       464/464
(100 %)
3 diff
(99.4 %id)
AI679458 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 354 to 1070 709 to 1       709/731
(96 %)
19 diff
(97.5 %id)
DA367754 subthalamic nucleus .a 365 to 919 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AI122932 pooled .a 383 to 912 530 to 1       530/530
(100 %)
11 diff
(98.0 %id)
FN107911 breast carcinoma .a 432 to 519 1 to 90       90/94
(95 %)
3 diff
(96.9 %id)
BM148904 leukopheresis .a 479 to 847 1 to 370       370/404
(91 %)
9 diff
(97.8 %id)
BM146535 leukopheresis .a 479 to 1043 1 to 566       566/566
(100 %)
4 diff
(99.3 %id)
FN104109 breast carcinoma .a 488 to 580 94 to 2     Submitted on the opposite strand 93/94
(98 %)
0 diff
(100 %id)
TI_1948151844   .a 505 to 1030 323 to 861       539/1357
(39 %)
58 diff
(95.8 %id)
DA844962 placenta .a 517 to 1089 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CX164768 human embryonic stem cells differentiated toan early endodermal cell type .a 529 to 1328 1 to 800       800/800
(100 %)
0 diff
(100 %id)
DA553490   .a 567 to 1136 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE243328 leukopheresis .a 622 to 1000 126 to 504       379/504
(75 %)
8 diff
(98.5 %id)
CT004479 T-Lymphocytes .a 632 to 1482 1 to 850       850/850
(100 %)
1 diff
(99.9 %id)
AI583919 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .a 635 to 1061 1 to 427     Submitted on the opposite strand 427/427
(100 %)
10 diff
(97.7 %id)
DA814689   .a 645 to 1224 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
AU131684   .a 653 to 1514 2 to 860   capped   859/859
(100 %)
5 diff
(99.5 %id)
BG942273 blood .a 654 to 1072 1 to 419       419/426
(98 %)
3 diff
(99.3 %id)
AU127833   .a 656 to 1403 2 to 751   capped   748/767
(97 %)
14 diff
(98.2 %id)
BM894208 insulinoma, Pancreas .a 719 to 1096 381 to 4   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 378/381
(99 %)
2 diff
(99.5 %id)
T59208 fetal spleen, Spleen .a 725 to 908 1 to 184       184/184
(100 %)
0 diff
(100 %id)
DA794795 brain .a 738 to 1201 2 to 465   capped   464/464
(100 %)
1 diff
(99.8 %id)
DA488648 brain .a 740 to 1292 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB206764 trachea .a 748 to 1335 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
BX349125   .a 882 to 1779 12 to 905       894/907
(98 %)
11 diff
(98.8 %id)
F08104 brain, total brain .a 921 to 1235 1 to 315       315/316
(99 %)
1 diff
(99.7 %id)
F13440 brain, total brain .a 921 to 1227 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
R34903 whole brain .a 922 to 1275 1 to 363       363/363
(100 %)
10 diff
(97.3 %id)
BE160134 head_neck .a 924 to 1264 9 to 348       340/348
(97 %)
7 diff
(98.0 %id)
BP290841 lung .a 928 to 1484 1 to 559       559/559
(100 %)
8 diff
(98.6 %id)
AU136923 placenta .a 932 to 1629 2 to 709   capped   706/729
(96 %)
16 diff
(97.9 %id)
DA539192 Kidney .a 945 to 1489 12 to 556   capped   545/555
(98 %)
9 diff
(98.4 %id)
T65340 whole brain .a 948 to 1310 1 to 377       377/430
(87 %)
20 diff
(95.4 %id)
DA302132 hippocampus .a 967 to 1430 8 to 471   capped   464/464
(100 %)
0 diff
(100 %id)
BE781164 eye, retinoblastoma .a 998 to 1703 1 to 711       711/779
(91 %)
22 diff
(97.2 %id)
DW449526 Liver .a 1016 to 1203 16 to 203       188/203
(92 %)
8 diff
(96.1 %id)
DA746830   .a 1029 to 1599 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BF132826 lung, mucoepidermoid carcinoma .a 1101 to 1812 1 to 708       708/712
(99 %)
18 diff
(97.5 %id)
AA095444   .a 1103 to 1320 1 to 214       214/214
(100 %)
4 diff
(98.2 %id)
BP429997   .a 1103 to 1510 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
DA223110 brain .a 1132 to 1715 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BF977508 melanotic melanoma, high MDR, skin .a 1160 to 1828 1 to 664       664/667
(99 %)
13 diff
(98.1 %id)
BG028239 Bone, osteosarcoma, cell line .a 1214 to 1970 1 to 745       745/954
(78 %)
9 diff
(99.1 %id)
TI_159714774   .a 1216 to 2045 884 to 67   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 818/1074
(76 %)
18 diff
(98.4 %id)
FN084479 breast carcinoma .a 1220 to 1305 1 to 85       85/85
(100 %)
1 diff
(98.9 %id)
BX483740   .a 1222 to 1920 1 to 699       699/699
(100 %)
5 diff
(99.3 %id)
DA601091   .a 1238 to 1819 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
CN314388 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1256 to 2013 10 to 767       758/767
(98 %)
6 diff
(99.3 %id)
AA191036   .a 1276 to 1699 1 to 429       429/430
(99 %)
6 diff
(98.7 %id)
R17895 whole brain .a 1294 to 1612 1 to 322     Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 322/332
(96 %)
3 diff
(99.1 %id)
BP205602 coronary artery .a 1304 to 1884 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB009763 colon, tumor tissue .a 1308 to 1874 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
T81266 whole brain .a 1316 to 1737 1 to 430     Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 430/476
(90 %)
22 diff
(95.4 %id)
BF217466 brain, glioblastoma .a 1331 to 1967 1 to 637       637/1016
(62 %)
22 diff
(97.9 %id)
AI279537 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1358 to 1877 520 to 1       520/520
(100 %)
7 diff
(98.7 %id)
BE149776 head_neck .a 1378 to 1718 26 to 366       341/402
(84 %)
11 diff
(97.3 %id)
BU073210 insulinoma, Pancreas .a 1388 to 2045 662 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 658/662
(99 %)
0 diff
(100 %id)
DA539589 Kidney .a 1395 to 1974 11 to 590   capped   580/589
(98 %)
9 diff
(98.5 %id)
CB306835 Human Lung Epithelial cells, lung .a 1395 to 2045 659 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 651/667
(97 %)
3 diff
(99.6 %id)
AI143113 heart .a 1412 to 1923 517 to 6       512/517
(99 %)
1 diff
(99.9 %id)
AA361072   .a 1426 to 1752 1 to 327       327/327
(100 %)
0 diff
(100 %id)
AW959030   .a 1427 to 2065 1 to 643       643/648
(99 %)
19 diff
(97.1 %id)
DW408813 Liver .a 1462 to 1785 17 to 341       325/341
(95 %)
14 diff
(95.9 %id)
BU517194 leiomyosarcoma, uterus .a 1469 to 2204 1 to 770       600/932
(64 %)
38 diff
(96.0 %id)
AW268817 pooled .a 1478 to 2036 559 to 1       559/559
(100 %)
6 diff
(99.0 %id)
AA811533 germinal center B cell .a 1481 to 1949 493 to 25       469/493
(95 %)
2 diff
(99.6 %id)
BX350355   .a 1491 to 2378 886 to 1       886/890
(99 %)
11 diff
(98.8 %id)
BG475155 melanotic melanoma, skin .a 1494 to 2137 1 to 680       483/680
(71 %)
26 diff
(96.2 %id)
BF214089 bone marrow, from acute myelogenous leukemia .a 1495 to 2130 1 to 631       631/872
(72 %)
44 diff
(95.0 %id)
BE275179 melanotic melanoma, skin .a 1514 to 2333 1 to 820       820/821
(99 %)
22 diff
(97.4 %id)
BF025810 melanotic melanoma, skin .a 1514 to 2201 1 to 684       684/965
(70 %)
9 diff
(99.1 %id)
BI048250 stomach .a 1519 to 1930 434 to 23       412/434
(94 %)
0 diff
(100 %id)
AI221677 pooled .a 1550 to 2035 485 to 1       485/512
(94 %)
12 diff
(97.7 %id)
FN056382 breast carcinoma .a 1592 to 1708 117 to 1     Submitted on the opposite strand 117/117
(100 %)
0 diff
(100 %id)
BF744457 breast .a 1607 to 2077 17 to 487       471/487
(96 %)
8 diff
(98.4 %id)
BG178910 adenocarcinoma, cell line, Prostate .a 1638 to 2342 10 to 712       703/895
(78 %)
23 diff
(97.5 %id)
CN314391 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1653 to 2328 1 to 677       677/677
(100 %)
1 diff
(99.9 %id)
CD679211 eye, Trabecular meshwork .a 1657 to 1869 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
T65147 whole brain .a 1661 to 2036 386 to 1       382/437
(87 %)
14 diff
(96.8 %id)
AA249176   .a 1670 to 2070 1 to 399       399/403
(99 %)
3 diff
(99.3 %id)
BG897659 cartilage .a 1671 to 2125 95 to 549       455/487
(93 %)
10 diff
(98.0 %id)
AA768053 germinal center B cell .a 1681 to 2041 363 to 4       360/363
(99 %)
1 diff
(99.8 %id)
BE000290 breast_normal .a 1683 to 1802 6 to 125       120/128
(93 %)
9 diff
(93.0 %id)
AV682172 hepatocellular carcinoma .a 1689 to 2174 21 to 506       486/669
(72 %)
7 diff
(99.0 %id)
CN314390 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1692 to 2107 1 to 416       416/416
(100 %)
0 diff
(100 %id)
F09494 brain, total brain .a 1709 to 2035 327 to 1       327/327
(100 %)
0 diff
(100 %id)
BE092645 breast .a 1714 to 2028 315 to 2     Submitted on the opposite strand 314/318
(98 %)
3 diff
(99.1 %id)
TI_1948149207   .a 1714 to 2724 1133 to 116       1018/1410
(72 %)
21 diff
(98.6 %id)
BE172099 head_neck .a 1724 to 1903 1 to 181       181/190
(95 %)
7 diff
(96.4 %id)
BE928027 colon .a 1738 to 1898 1 to 159       159/159
(100 %)
3 diff
(98.2 %id)
BE928061 colon .a 1738 to 1879 152 to 13       140/152
(92 %)
2 diff
(98.7 %id)
BE928072 colon .a 1738 to 1879 152 to 13       140/152
(92 %)
2 diff
(98.7 %id)
BQ427606 melanotic melanoma, skin .a 1749 to 2543 36 to 840       805/898
(89 %)
18 diff
(98.0 %id)
BQ427813 melanotic melanoma, skin .a 1749 to 2587 36 to 881       846/891
(94 %)
20 diff
(97.8 %id)
CD107746 brain, Pituitary .a 1753 to 2551 42 to 847       806/847
(95 %)
19 diff
(97.8 %id)
BP219269 caudate nucleus .a 1764 to 2343 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
Z41177 brain, total brain .a 1781 to 2035 255 to 1       255/255
(100 %)
0 diff
(100 %id)
BM505336 Pancreas, Purified pancreatic islet .a 1806 to 2416 18 to 629     Submitted on the opposite strand 612/629
(97 %)
8 diff
(98.8 %id)
TI_1948148842   .a 1817 to 2724 1019 to 114       906/1317
(68 %)
30 diff
(97.8 %id)
BF982513 duodenal adenocarcinoma, cell line, small intestine .a 1820 to 2576 1 to 756       756/763
(99 %)
12 diff
(98.5 %id)
BF683110 leiomyosarcoma cell line, uterus .a 1823 to 2314 1 to 507       506/600
(84 %)
35 diff
(94.2 %id)
BM718344 eye, fetal eye .a 1826 to 2445 1 to 620   fully sequenced, Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 620/620
(100 %)
3 diff
(99.6 %id)
CN314395 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1839 to 2581 10 to 753       744/753
(98 %)
7 diff
(99.1 %id)
BI222621 cervical carcinoma cell line, cervix .a 1852 to 2651 1 to 801       801/803
(99 %)
12 diff
(98.6 %id)
BP200850 amygdala .a 1857 to 2302 1 to 446       446/455
(98 %)
3 diff
(99.4 %id)
BG431157 Kidney .a 1859 to 2616 1 to 753       754/788
(95 %)
13 diff
(98.4 %id)
BU192616 eye, retinoblastoma .a 1870 to 2706 1 to 839       839/839
(100 %)
9 diff
(99.0 %id)
TI_1948148880   .a 1878 to 2724 967 to 121       847/1362
(62 %)
37 diff
(97.3 %id)
TI_1948149208   .a 1880 to 2724 964 to 118       847/1376
(61 %)
14 diff
(99.0 %id)
TI_1948148286   .a 1882 to 2724 964 to 117       848/1395
(60 %)
22 diff
(98.5 %id)
FN103149 breast carcinoma .a 1895 to 2003 107 to 1     Submitted on the opposite strand 108/107
(100 %)
3 diff
(97.2 %id)
FN157342 breast carcinoma .a 1900 to 1992 93 to 1     Submitted on the opposite strand 91/97
(93 %)
2 diff
(98.0 %id)
AA044750 uterus .a 1908 to 2438 1 to 529       529/529
(100 %)
6 diff
(98.9 %id)
DT220290 brain .a 1910 to 2240 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
BE140574 head_neck .a 1948 to 2327 380 to 1     Submitted on the opposite strand 380/380
(100 %)
0 diff
(100 %id)
BE140795 head_neck .a 1948 to 2327 380 to 1     Submitted on the opposite strand 380/380
(100 %)
1 diff
(99.8 %id)
FN068153 breast carcinoma .a 1950 to 2033 1 to 85       85/89
(95 %)
2 diff
(97.8 %id)
AI909768 breast .a 1959 to 2327 36 to 404       369/404
(91 %)
6 diff
(98.6 %id)
TI_1948148249   .a 1959 to 2724 887 to 117       771/1489
(51 %)
23 diff
(98.5 %id)
TI_1948148587   .a 1959 to 2724 897 to 124       774/1514
(51 %)
19 diff
(98.8 %id)
TI_1948148881   .a 1959 to 2724 886 to 118       769/1389
(55 %)
25 diff
(98.3 %id)
CN314392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1961 to 2740 8 to 786       779/786
(99 %)
11 diff
(98.7 %id)
BF105298 Kidney .a 1961 to 2273 5 to 345       341/345
(98 %)
13 diff
(96.3 %id)
TI_1948148586   .a 1961 to 2724 821 to 53       769/1315
(58 %)
8 diff
(99.4 %id)
TI_1948148843   .a 1961 to 2724 882 to 116       767/1442
(53 %)
21 diff
(98.6 %id)
TI_1948149162   .a 1961 to 2724 888 to 124       765/1433
(53 %)
14 diff
(99.1 %id)
TI_1948148285   .a 1974 to 2712 744 to 1       744/1216
(61 %)
25 diff
(98.0 %id)
CB160730 Liver .a 1992 to 2568 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
TI_1948149161   .a 2002 to 2724 848 to 123       726/1379
(52 %)
42 diff
(97.0 %id)
AW845210 colon .a 2010 to 2327 1 to 317       317/317
(100 %)
2 diff
(99.4 %id)
TI_1948148548   .a 2029 to 2724 820 to 116       705/1468
(48 %)
27 diff
(98.2 %id)
BP248796 Kidney .a 2035 to 2614 1 to 581       581/585
(99 %)
4 diff
(99.4 %id)
ES314093 occipital scalp hair, skin .a 2048 to 2300 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BF813646 colon_ins .a 2057 to 2463 407 to 1     Submitted on the opposite strand 407/407
(100 %)
1 diff
(99.8 %id)
DW418566 Liver .a 2075 to 2465 422 to 29   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 394/422
(93 %)
1 diff
(99.8 %id)
AL580487 T cells from T cell leukemia .a 2078 to 2981 903 to 1       903/903
(100 %)
64 diff
(93.0 %id)
CF143619 lymph .a 2144 to 2643 1 to 500       500/500
(100 %)
4 diff
(99.2 %id)
CF135420 lymph .a 2144 to 2688 1 to 546       546/546
(100 %)
5 diff
(99.1 %id)
TI_154163744   .a 2151 to 2944 72 to 859       788/1247
(63 %)
36 diff
(97.2 %id)
TI_154175089   .a 2151 to 2715 80 to 648       569/709
(80 %)
7 diff
(99.1 %id)
DW423033 Liver .a 2172 to 2445 17 to 290       274/293
(93 %)
12 diff
(96.0 %id)
BU933396 mixed (pool of 40 RNAs) .a 2172 to 3003 1 to 846       846/849
(99 %)
29 diff
(96.6 %id)
AW752452 colon .a 2178 to 2505 1 to 323       323/324
(99 %)
14 diff
(95.7 %id)
BF035463 adenocarcinoma, ovary .a 2206 to 2833 1 to 630       630/1089
(57 %)
10 diff
(99.1 %id)
TI_154111435   .a 2206 to 3041 911 to 85   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 827/966
(85 %)
10 diff
(99.0 %id)
BI857174 breast, mammary adenocarcinoma, cell line .a 2225 to 3050 43 to 884       842/903
(93 %)
54 diff
(94.1 %id)
TI_57186837   .a 2225 to 3050 102 to 943       842/903
(93 %)
54 diff
(94.1 %id)
BE243244 leukopheresis .a 2241 to 2396 169 to 14       156/169
(92 %)
0 diff
(100 %id)
TI_149313936   .a 2244 to 3050 895 to 92   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 804/973
(82 %)
7 diff
(99.3 %id)
TI_149308304   .a 2249 to 3041 870 to 86   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 785/931
(84 %)
16 diff
(98.3 %id)
BU587780 mixed (pool of 40 RNAs) .a 2287 to 2465 1 to 179   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 179/191
(93 %)
10 diff
(94.8 %id)
BU623810 cell lines, Enchondroma .a 2300 to 3050 768 to 19   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 750/750
(100 %)
1 diff
(99.9 %id)
CA448370 Chondrosarcoma, Left Pubic Bone .a 2303 to 3046 743 to 1       743/743
(100 %)
2 diff
(99.8 %id)
AA843664 parathyroid gland, parathyroid tumor .a 2311 to 3047 740 to 2       739/741
(99 %)
16 diff
(97.9 %id)
BI918547 brain .a 2323 to 3037 1 to 717       717/717
(100 %)
9 diff
(98.8 %id)
TI_57238709   .a 2323 to 3037 1 to 717       717/717
(100 %)
9 diff
(98.8 %id)
DN912916   .a 2329 to 3031 17 to 712       696/713
(97 %)
19 diff
(97.4 %id)
DN915795   .a 2329 to 2960 18 to 649       632/649
(97 %)
11 diff
(98.4 %id)
DN913123   .a 2331 to 2984 19 to 672       654/683
(95 %)
7 diff
(99.0 %id)
BE878695 large cell carcinoma, undifferentiated, lung .a 2335 to 3027 698 to 1     Submitted on the opposite strand 698/789
(88 %)
33 diff
(95.9 %id)
DN917830   .a 2336 to 3011 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
DN920564   .a 2336 to 2510 1 to 175       175/175
(100 %)
0 diff
(100 %id)
AI300080 2 pooled tumors (clear cell type), Kidney .a 2349 to 3054 713 to 5       709/714
(99 %)
6 diff
(99.2 %id)
BU616575 Cell Line, Chondrosarcoma .a 2360 to 3039 684 to 5       680/684
(99 %)
1 diff
(99.9 %id)
BQ009652 Chondrosarcoma, Left Pubic Bone .a 2361 to 3046 686 to 1       686/686
(100 %)
0 diff
(100 %id)
BU687154 lung, Primary Lung Epithelial Cells .a 2361 to 3046 686 to 1       686/686
(100 %)
0 diff
(100 %id)
CA422969 cell lines, Chondrosarcoma .a 2361 to 3054 698 to 6       693/698
(99 %)
1 diff
(99.9 %id)
BU620843 cell lines, Chondrosarcoma .a 2361 to 3054 699 to 6       694/699
(99 %)
0 diff
(100 %id)
BU683420 lung .a 2389 to 3050 680 to 19   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
CB305758 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2389 to 3050 680 to 19   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
BM992060 Bone, Subchondral Bone .a 2393 to 3054 667 to 6       662/667
(99 %)
0 diff
(100 %id)
BM793127 Ascites, stomach .a 2396 to 2923 13 to 539       527/539
(97 %)
6 diff
(98.9 %id)
BG187521   .a 2397 to 3050 4 to 660   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 657/660
(99 %)
8 diff
(98.8 %id)
BG188724   .a 2397 to 3045 1 to 649       649/649
(100 %)
11 diff
(98.4 %id)
BG218895   .a 2397 to 3052 1 to 656       656/792
(82 %)
11 diff
(98.7 %id)
BG210976   .a 2398 to 3050 1 to 653   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 653/653
(100 %)
7 diff
(99.0 %id)
BG198457   .a 2401 to 3028 1 to 628   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 628/628
(100 %)
3 diff
(99.6 %id)
BG208770   .a 2401 to 3045 1 to 642       642/642
(100 %)
8 diff
(98.8 %id)
BE169032 head_neck .a 2402 to 2527 135 to 13     Submitted on the opposite strand 123/135
(91 %)
0 diff
(100 %id)
BG195438   .a 2402 to 3031 644 to 16     Submitted on the opposite strand 629/644
(97 %)
10 diff
(98.5 %id)
BM509746 Pancreas, Purified pancreatic islet .a 2408 to 3034 630 to 4     Submitted on the opposite strand 627/630
(99 %)
0 diff
(100 %id)
AW189979 adenocarcinoma, Pancreas .a 2410 to 2714 299 to 1       299/301
(99 %)
16 diff
(94.7 %id)
BU741932 eye, fetal eye .a 2415 to 3050 652 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 634/634
(100 %)
1 diff
(99.9 %id)
AA621872 colon, colon tumor RER+ .a 2422 to 3049 645 to 19   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 627/627
(100 %)
2 diff
(99.7 %id)
FN066999 breast carcinoma .a 2424 to 2510 1 to 87       87/87
(100 %)
2 diff
(97.8 %id)
BE004869 breast_normal .a 2433 to 3030 624 to 28     Submitted on the opposite strand 597/635
(94 %)
7 diff
(98.9 %id)
DN913124   .a 2441 to 3033 638 to 49   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 590/593
(99 %)
3 diff
(99.5 %id)
BG206284   .a 2452 to 3050 58 to 652   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 595/652
(91 %)
7 diff
(99.0 %id)
BG181426   .a 2456 to 3028 99 to 671   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 573/671
(85 %)
6 diff
(99.2 %id)
AI951772 brain, four pooled pituitary adenomas .a 2456 to 3050 593 to 1       593/593
(100 %)
3 diff
(99.5 %id)
BM127392 Islets of Langerhans, Pancreas .a 2469 to 2714 246 to 1       246/247
(99 %)
6 diff
(97.6 %id)
FN158504 breast carcinoma .a 2474 to 2583 111 to 1     Submitted on the opposite strand 111/111
(100 %)
2 diff
(98.2 %id)
AI678897 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2477 to 3041 575 to 12   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 564/564
(100 %)
17 diff
(97.0 %id)
AI926598 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2483 to 3050 597 to 30   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 568/568
(100 %)
2 diff
(99.7 %id)
AU153384   .a 2492 to 3041 547 to 1       547/571
(95 %)
15 diff
(97.4 %id)
AU150261   .a 2499 to 3041 540 to 1       540/540
(100 %)
19 diff
(96.5 %id)
CD677008 eye, Trabecular meshwork .a 2506 to 3034 1 to 529       529/529
(100 %)
0 diff
(100 %id)
AI309602 2 pooled tumors (clear cell type), Kidney .a 2512 to 3044 532 to 1       532/534
(99 %)
11 diff
(98.0 %id)
AW608791 pnet .a 2517 to 2912 402 to 5       398/414
(96 %)
4 diff
(99.1 %id)
BE856878 pooled .a 2519 to 2855 337 to 1       337/337
(100 %)
5 diff
(98.6 %id)
N62813.
matches multiple genes
multiple sclerosis lesions .a 2526 to 3049 526 to 2     also hits gene NKAIN2 525/552
(95 %)
12 diff
(97.9 %id)
BG059634 brain, glioblastoma without EGFR amplification .a 2540 to 3041 502 to 1       502/502
(100 %)
0 diff
(100 %id)
DB374392 placenta .a 2551 to 3029 479 to 1       479/485
(98 %)
15 diff
(97.0 %id)
AI983138 pooled germ cell tumors .a 2557 to 3041 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AW875592 pnet .a 2563 to 2870 327 to 19       309/327
(94 %)
0 diff
(100 %id)
DB375804 placenta .a 2563 to 3034 480 to 8       473/543
(87 %)
8 diff
(98.6 %id)
AI655073 pooled germ cell tumors .a 2564 to 3041 478 to 1       478/478
(100 %)
2 diff
(99.6 %id)
AW875626 pnet .a 2569 to 2870 323 to 18       306/323
(94 %)
0 diff
(100 %id)
AA130606   .a 2572 to 3042 472 to 1       472/472
(100 %)
7 diff
(98.6 %id)
FN121013 breast carcinoma .a 2576 to 2676 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
AI370827   .a 2576 to 3054 479 to 3       477/479
(99 %)
0 diff
(100 %id)
C75554   .a 2596 to 3054 460 to 5       456/462
(98 %)
1 diff
(99.8 %id)
DV459175 cochlea, ear .a 2597 to 2722 1 to 126       126/126
(100 %)
1 diff
(99.3 %id)
AW263335 brain, three pooled meningiomas .a 2600 to 3041 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
C75528   .a 2613 to 3050 462 to 22   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 441/472
(93 %)
8 diff
(98.4 %id)
AI344426 2 pooled tumors (clear cell type), Kidney .a 2613 to 3054 443 to 2       442/450
(98 %)
0 diff
(100 %id)
BE004788 breast_normal .a 2626 to 3023 408 to 8     Submitted on the opposite strand 401/408
(98 %)
0 diff
(100 %id)
AA576220 breast, breast tumor .a 2630 to 3043 414 to 1       414/414
(100 %)
0 diff
(100 %id)
BF084549 colon .a 2631 to 2864 1 to 233       233/233
(100 %)
9 diff
(96.2 %id)
BP390003 pancreatic islet .a 2639 to 3044 1 to 406     Submitted on the opposite strand 406/406
(100 %)
0 diff
(100 %id)
BQ318550 colon .a 2643 to 2864 1 to 224       224/224
(100 %)
5 diff
(97.8 %id)
BF084475 colon .a 2644 to 2864 11 to 230       220/230
(95 %)
6 diff
(97.4 %id)
BF084458 colon .a 2650 to 2874 231 to 12       220/231
(95 %)
0 diff
(100 %id)
BF084578 colon .a 2650 to 2873 231 to 12       220/231
(95 %)
0 diff
(100 %id)
BF084602 colon .a 2650 to 2864 1 to 213       213/213
(100 %)
5 diff
(97.7 %id)
BQ318474 colon .a 2650 to 2870 223 to 5       219/223
(98 %)
0 diff
(100 %id)
BQ318503 colon .a 2650 to 2870 228 to 12       217/228
(95 %)
0 diff
(100 %id)
BP422217 small intestine .a 2657 to 3054 1 to 398     Submitted on the opposite strand 398/398
(100 %)
2 diff
(99.5 %id)
AA604824 adrenal adenoma, adrenal gland .a 2657 to 3051 395 to 1       395/395
(100 %)
0 diff
(100 %id)
BQ318460 colon .a 2659 to 2873 223 to 13       211/223
(94 %)
0 diff
(100 %id)
BQ318487 colon .a 2662 to 2864 6 to 209       204/209
(97 %)
6 diff
(97.2 %id)
AI350912 pooled germ cell tumors .a 2668 to 3047 379 to 1       379/548
(69 %)
1 diff
(99.9 %id)
AI431405 adenocarcinoma, Pancreas .a 2669 to 3041 384 to 12   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
AA749378 germinal center B cell .a 2677 to 3050 402 to 29   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
R38882 whole brain .a 2690 to 3050 378 to 11   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 368/368
(100 %)
10 diff
(97.3 %id)
C75657   .a 2717 to 3050 345 to 12   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 334/334
(100 %)
0 diff
(100 %id)
AA173821.
matches multiple genes
  .a 2719 to 3051 338 to 3     Submitted on the opposite strand, also hits gene TMEM97 336/338
(99 %)
0 diff
(100 %id)
AA219672 brain, neuroepithelial cells .a 2739 to 2943 206 to 1       206/206
(100 %)
1 diff
(99.6 %id)
AW768408 lymph node, lymphoma, follicular mixed small and largecell .a 2754 to 3043 291 to 1       291/291
(100 %)
1 diff
(99.7 %id)
DB512526 testis .a 2766 to 3041 1 to 276     Submitted on the opposite strand 276/276
(100 %)
6 diff
(97.9 %id)
BU960123 mixed (pool of 40 RNAs) .a 2776 to 3041 1 to 266   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 266/266
(100 %)
1 diff
(99.7 %id)
R43141 whole brain .a 2784 to 3050 287 to 12   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 276/276
(100 %)
9 diff
(96.8 %id)
AI431414 adenocarcinoma, Pancreas .a 2795 to 3041 258 to 12   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 247/247
(100 %)
1 diff
(99.6 %id)
AA483343 alveolar rhabdomyosarcoma .a 2799 to 3043 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
AI673792 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2826 to 3051 226 to 1       226/226
(100 %)
0 diff
(100 %id)
T17294   .a 2844 to 3050 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
BF327552 breast_normal .a 2859 to 3030 1 to 171       171/173
(98 %)
3 diff
(98.3 %id)
AW770187 lymph node, lymphoma, follicular mixed small and largecell .a 2910 to 3041 148 to 17   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 132/132
(100 %)
0 diff
(100 %id)
BG389970 embryonal carcinoma, cell line, testis .a 3274 to 4035 1 to 765       765/878
(87 %)
18 diff
(98.0 %id)
CN314389 embryonic stem cells, cell lines H1, H7, andH9 .a 3445 to 4129 1 to 685       685/685
(100 %)
2 diff
(99.8 %id)
BE168049 head_neck .a 3704 to 4255 14 to 562       549/562
(97 %)
6 diff
(99.0 %id)
BI040898 nervous_tumor .a 4178 to 4336 12 to 168       157/282
(55 %)
6 diff
(97.9 %id)
TI_149279609   .a 4298 to 4959 724 to 63   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 662/1092
(60 %)
0 diff
(100 %id)
BM969643 lung, Primary Lung Epithelial Cells .a 4298 to 4959 678 to 17   AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 662/679
(97 %)
0 diff
(100 %id)
AI476404 pooled .a 4541 to 5026 485 to 4       482/485
(99 %)
0 diff
(100 %id)
AI088288 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4688 to 5158 471 to 1       471/471
(100 %)
0 diff
(100 %id)
BF240486 bone marrow, from acute myelogenous leukemia .a 4716 to 5437 1 to 711       711/924
(76 %)
30 diff
(96.8 %id)
AA654152 epithelium (cell line), Prostate .a 4814 to 5161 349 to 2       348/349
(99 %)
0 diff
(100 %id)
CN314383 embryonic stem cells, cell lines H1, H7, andH9 .a 4838 to 5441 1 to 605   tiling clone,   605/605
(100 %)
3 diff
(99.6 %id)
AW974864   .a 4847 to 5156 311 to 1     Submitted on the opposite strand 311/311
(100 %)
8 diff
(97.5 %id)
BE567049 bladder, carcinoma, cell line .a 5464 to 6016 1 to 553       553/555
(99 %)
46 diff
(91.8 %id)
BX424398 thymus .a 5560 to 6406 1 to 846       846/846
(100 %)
12 diff
(98.6 %id)
BX436572 thymus .a 5563 to 6433 1 to 867       867/938
(92 %)
13 diff
(98.7 %id)
CB044283 colon, juvenile granulosa tumor .a 5753 to 6300 5 to 552   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 548/552
(99 %)
5 diff
(99.1 %id)
BX436571 thymus .a 6103 to 6911 815 to 1   tiling clone,   815/867
(94 %)
23 diff
(97.4 %id)
BM014881 breast, mammary adenocarcinoma, cell line .a 6128 to 6690 189 to 748       560/748
(74 %)
6 diff
(99.2 %id)
TI_59392960   .a 6128 to 6690 272 to 831       560/748
(74 %)
6 diff
(99.2 %id)
CB044282 colon, juvenile granulosa tumor .a 6270 to 6813 571 to 28   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 544/544
(100 %)
0 diff
(100 %id)
BF790457 muscle (skeletal) .a 6300 to 6936 1 to 632   tiling clone,   632/650
(97 %)
13 diff
(98.0 %id)
DT215265 brain .a 6441 to 6706 1 to 266       266/266
(100 %)
4 diff
(98.5 %id)
BQ961587 leiomyosarcoma, uterus .b 1 to 840 1 to 845 N216T Q217R V218C W219G E220K ... tiling clone,   845/918
(92 %)
20 diff
(97.9 %id)
BQ962695 leiomyosarcoma, uterus .b 1 to 766 1 to 770 E180X K184I W219* tiling clone,   867/915
(94 %)
25 diff
(97.3 %id)
W04385 lung .c 1 to 359 1 to 359   tiling clone,   359/361
(99 %)
4 diff
(98.9 %id)
N74285 lung .c 419 to 790 380 to 1   tiling clone,   380/462
(82 %)
12 diff
(97.5 %id)
BE087234 breast .d 1 to 379 385 to 8   tiling clone, Submitted on the opposite strand 378/385
(98 %)
0 diff
(100 %id)
TI_149294792   .d 173 to 1025 925 to 84 A2K L3F S4I L5S P6S ... tiling clone, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 842/969
(86 %)
55 diff
(94.4 %id)
BM144745 leukopheresis .e 1 to 450 488 to 39 T11P T18A L20V E104Q tiling clone, AAA   450/472
(95 %)
5 diff
(99.0 %id)
AW341844 pooled .e 106 to 554 448 to 1   tiling clone,   448/448
(100 %)
4 diff
(99.2 %id)
BF510896   .e 289 to 555 283 to 18   tiling clone, AAA   266/266
(100 %)
3 diff
(98.9 %id)
BM565019 insulinoma, Pancreas .f 1 to 540 1 to 540   tiling clone,   540/540
(100 %)
5 diff
(99.1 %id)
BU789934 insulinoma, Pancreas .f 1 to 568 1 to 568       568/568
(100 %)
5 diff
(99.2 %id)
BU789887 insulinoma, Pancreas .f 1 to 559 1 to 559     Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 559/559
(100 %)
5 diff
(99.2 %id)
BM698342 eye, fetal eyes .f 397 to 766 1 to 371   tiling clone,   371/371
(100 %)
1 diff
(99.8 %id)
BU789615 insulinoma, Pancreas .f 743 to 1385 659 to 17 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/19 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
BU736099 eye, fetal eyes .f 943 to 1398 461 to 6   tiling clone,   456/461
(98 %)
0 diff
(100 %id)
BM512418 insulinoma, Pancreas .f 1156 to 1360 199 to 1       199/199
(100 %)
6 diff
(97.0 %id)
AA325975 brain, cerebellum .g-u 1 to 373 1 to 374 F28X tiling clone,   374/377
(99 %)
4 diff
(99.0 %id)
AF090903 Liver Gene CDC5L, variant not shown       AAA Submitted on the opposite strand    
AK299738 brain Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
CD702878 normal nasopharynx Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
AV654201 corresponding non cancerous liver tissue Gene CDC5L, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AI473246 Kidney Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
CB052717 leiomyosarcoma, soft tissue Gene CDC5L, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CB052718 leiomyosarcoma, soft tissue Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
BF693393 muscle (skeletal) Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
BG471901 eye, retinoblastoma Gene CDC5L, variant not shown         This clone was ignored    
DC376462 brain Gene CDC5L, variant not shown         Suspected internal deletion, this clone was ignored    
DB118444 thymus Gene CDC5L, variant not shown       capped This clone was ignored    
DB343808 thymus Gene CDC5L, variant not shown         This clone was ignored    
DB204545 trachea Gene CDC5L, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI